Latest Reported Offering
$25,000
Target Amount
$5,000,000
Maximum Amount
2022-04-30
Deadline
Security Details
Type: Common Stock
Price per share: $2.21
Shares offered: 2,262,443+
Offering Costs
Cash commission: 4%
of all sums raised in this offering (1% of which will be delivered in Class B Non-Voting Common Stock), plus a $25,000 fee.
Equity compensation: —
Dalmore Group LLC will receive the company's Class B Non-Voting Common Stock equal to 1% of aggregate amount raised.
Filing history
Form C family — 4 filings| Filed | Form | File number | Portal | What it states | What the filer said |
|---|---|---|---|---|---|
| 2022-05-19 | C-TR | 020-28153 | Dalmore Group LLC | — | — |
| 2022-05-19 | C-AR | 020-28153 | Dalmore Group LLC | Revenue $0 · net income -$2.2M · 2 employees | — |
| 2022-05-02 | C-U | 020-28153 | Dalmore Group LLC | $25K target, up to $5M · Common Stock at $2.21 · closes 2022-04-30 | The company sold approximately 23,481 shares of Class B Non-Voting Common Stock for gross proceeds of $51,893 |
| 2021-05-25 | C | 020-28153 | Dalmore Group LLC | $25K target, up to $5M · Common Stock at $2.21 · closes 2022-04-30 | — |
The reported figures behind SafeRx Pharmaceuticals Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Company Information
Legal Status
Corporation
Jurisdiction
DE
Date of Incorporation
2020-06-22
Latest Metrics
Employees2
Total Assets$267,690
Cash on Hand$267,690
Revenues$0.00
Net Income-$2,225,334
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.